Zhengye Biotechnology Holding (ZYBT) Inventory (2023 - 2025)

Zhengye Biotechnology Holding (ZYBT) has reported Inventory for 3 consecutive years, with $5.5 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Inventory fell 31.87% year-over-year to $5.5 million in Q4 2025; TTM through Dec 2025 was $5.5 million, a 31.87% decrease from a year earlier, with the FY2025 full-year figure at $5.6 million, down 29.79% from the prior year.
• Inventory was $5.5 million for Q4 2025 at Zhengye Biotechnology Holding, down from $7.5 million in the prior quarter.
• Over five years, Inventory peaked at $8.1 million in Q4 2024 and troughed at $5.5 million in Q4 2025.
• A 3-year average of $7.3 million and a median of $7.8 million in 2023 frame the typical range for Inventory.
• Across the five-year window, Inventory climbed 0.1% in 2024 and plunged 31.87% in 2025, its largest moves.
• Over 3 years, Inventory stood at $8.1 million in 2023, then increased by 0.1% to $8.1 million in 2024, then slumped by 31.87% to $5.5 million in 2025.
• The last three Inventory figures came in at $5.5 million (Q4 2025), $7.5 million (Q2 2025), and $8.1 million (Q4 2024), per Business Quant data.